Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Pens that have been frozen, exposed to excessive heat, or stored beyond their expiration date may have reduced potency
Examines the benefits and tolerability of GLP-1 medications in obesity treatment
Currently, appendicitis is not listed as a common side effect, but it has appeared in the safety data of several large-scale clinical trials
This results in a more comprehensive and sustainable improvement in overall metabolic health
However, the landmark SURMOUNT-5 trial (published in mid-2025), which compared the two medications head-to-head, clarified the clinical reality: Total Weight Loss: Tirzepatide drives significantly greater total weight loss (averaging over 20%) compared to semaglutide (averaging roughly 14%)
US$ 25.67
US$ 29.07
US$ 20.38
